Data suggests that GSK-Vir treatment is effective against Omicron sub-variant

According to results from lab studies, an antibody-based COVID-19 therapy developed by GSK and Vir Biotechnology preserves neutralising activity against the developing BA.2 type of the Omicron coronavirus variant.

The business stated it would reveal preprint data in the coming week, followed by live viral data.

According to the business, the 500 mg dose of sotrovimab is sufficient to maintain action against the BA.2 variation, which is in line with all other variants of concern and interest, based on pseudovirus and substantial pharmacokinetic data.
Sotrovimab is one of the few COVID-19 therapies that has been demonstrated to act against the fast-spreading Omicron form, which has sparked interest. In 2021, it was one of GSK’s best-selling products.

Medically Speaking

Recent Posts

ANTIBIOTIC MISUSE IN INDIA: HOW IT’S MAKING INFECTION TREATMENT MORE CHALLENGING

Antibiotic use has surged globally, leading to a rise in antibiotic resistance, especially concerning in…

13 hours ago

CHILD DIES FROM CHOKING ON CANDY: HOW TO SAFEGUARD AGAINST CHOKING HAZARDS IN YOUNG CHILDREN

Choking is a leading cause of injury and death in young children, particularly those under…

14 hours ago

Video: How Hard Water Leads to Hair Fall and Expert Tips to Combat It

Hard Water (Khara Pani) Leading To Hair Fall Hard water is rich in minerals and…

16 hours ago

“How High Blood Pressure During Pregnancy Is Rising: What Every Expectant Mother Should Know”

Discover how the rise in high blood pressure during pregnancy is impacting maternal and fetal…

16 hours ago

“Revitalize Your Weight Loss Journey: 6 Powerful Homemade Drinks to Naturally Melt Away Fat!”

"Discover the transformative power of six delicious homemade drinks that can help you naturally melt…

16 hours ago

“Revitalize Your Weight Loss Journey: 8 Powerful Fat-Flushing Drinks to Boost Your Results!”

"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…

16 hours ago